Axsome Therapeutics stockAXSM
Axsome Therapeutics trades at $129.80, 50.1% below its 52-week high (Jun 18, 2026). The price is below its 50- and 200-day averages, a downtrend. −28.9% year to date, −4.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 1, 2027.
Ratings, candles, signals and the screener for AXSM — after you log in
Open the terminalFrequently asked questions about Axsome Therapeutics
What is the Axsome Therapeutics stock price?
At the close on Nov 5, 2026: $129.80 (−5.26% on the day). 52-week high: $260.19 on Jun 18, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Axsome Therapeutics report earnings?
The next quarterly report is on Mar 1, 2027. Last quarter, earnings per share changed +73% year over year, revenue +52%.
Does Axsome Therapeutics pay dividends?
No, Axsome Therapeutics does not pay dividends.
Where does Axsome Therapeutics trade and how to buy it?
Ticker AXSM, exchange Nasdaq, listed since 2015. You can buy it through a broker with access to US exchanges.
Should I buy Axsome Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for AXSM are in the terminal after you log in.